Grown Rogue International (GRUSF) Interest Expenses (2009 - 2026)

Grown Rogue International's (GRUSF) quarterly Interest Expenses came in at $768885.0 in Q1 2026, up 749.09% year-on-year from $90554.1 in Q1 2025, and down 100.0% quarter-over-quarter from $400.9 billion in Q4 2025.

Grown Rogue International (GRUSF) Interest Expenses (2009 - 2026) Analysis & Trends

Grown Rogue International's Interest Expenses history runs 18 years deep, the most recent figure standing at $768885.0 for Q1 2026.

  • On a quarterly basis, Interest Expenses rose 749.09% year-over-year to $768885.0 in Q1 2026; TTM through Mar 2026 was $768885.0, a 100.0% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, down 59.46% from the prior year.
  • Interest Expenses fell to $768885.0 in Q1 2026 per GRUSF's latest filing, from $400.9 billion in the prior quarter.
  • Across five years, Interest Expenses topped out at $400.9 billion in Q4 2025 and bottomed at -$125.2 billion in Q3 2025.
  • The 5-year median for Interest Expenses is -$114660.0 (2022), against an average of $13.4 billion.
  • Across the five-year window, Interest Expenses sank 1444.67% in 2022 and soared 749.09% in 2026, its largest moves.
  • Year by year, Interest Expenses stood at -$114660.0 in 2022, then sank by 136.45% to -$271112.0 in 2023, then tumbled by 37527563.84% to -$101.7 billion in 2024, then soared by 494.07% to $400.9 billion in 2025, then tumbled by 100.0% to $768885.0 in 2026.
  • Per Business Quant, the three latest GRUSF Interest Expenses figures stand at $768885.0 (Q1 2026), $400.9 billion (Q4 2025), and -$125.2 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 944.51 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.77 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 2.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.21 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 590.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn 768,885.00

Historic Data

Download Data
DateValue
Mar 31, 2026 768,885.00
Mar 31, 2026 768,885.00
Dec 31, 2025 400.94 Bn
Dec 31, 2025 400.94 Bn
Sep 30, 2025 -125.20 Bn
Sep 30, 2025 -125.20 Bn
Jun 30, 2025 -157,283.00
Jun 30, 2025 -157,283.00
Mar 31, 2025 -118,456.00
Mar 31, 2025 -118,456.00
Sep 30, 2024 -101.74 Bn
Sep 30, 2024 -101.74 Bn
Jun 30, 2024 -58,225.11
Jun 30, 2024 -58,225.11
Mar 31, 2024 -89,687.00
Mar 31, 2024 -89,687.00
Oct 31, 2023 -271,112.00
Oct 31, 2023 -271,112.00
Jul 31, 2023 -185,686.00
Jul 31, 2023 -185,686.00